Loading…
Based on limited metadata, B & J Group received an FDA Warning Letter on January 19, 2023, regarding drug products, with three identified violations. Without access to the full letter text or specific subject matter details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulatory authority, though the specific issuing office is not documented in this metadata summary.